|
|
|
| home > pmps > autumn 2003 > quality: a strategic element in the success of a company |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The convention opened with a short introduction by Sergio Dompé, President of the convention organiser and the Chairman, Prof Andrea Gazzaniga, Professor of Pharmacy at the University of Milano, who warmly welcomed the upcoming lectures by key experts from across the world in pharmaceutical quality issues. Dr Henning G Kristensen, who at present serves as the Chair of the European Commission and is a member of the Steering committee for the Certificates of Suitability of Drug Substances, spoke first, on The European Pharmacopoeia and its role in the regulatory process, highlighting the difficulties found in the integration of the Pharmacopoeias in the differing European countries.
The message was that European countries need to speak a common technical language and establish an international harmonisation of subjects. Certain uniformity in the terminology related to pharmaceutical products' qualitative characteristics and in the impurities controls, both for the active pharmaceutical ingredients (API) and excipients and for the container materials, should be reached in the next few years. In the 4th Edition of European Pharmacopoeia it is stated that those standards have to be appropriate to the needs of all people engaged in quality controls laboratories and in the manufacturers of starting materials too.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec –
and Dizal Pharmaceutical, a biotechnology company, announce a strategic
partnership. Under the terms of the collaboration, WuXi STA will become
the preferred CDMO partner of Dizal Pharmaceutical for GMP production,
providing integrated CMC (Chemical, manufacturing and Control) process
research and manufacturing services from API to drug product.
More info >> |
|
 |
White Papers |
 |
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
Aptar Pharma
Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >> |
|
 |
Industry Events |
 |
Nordic Life Science Days 10/12 September 2019
10-12 September 2019, Malmo Sweden
Nordic Life Science Days is the largest Nordic partnering conference for the global Life
Science industry.
Bringing together the best talents in Life Science, offering amazing networking and
partnering opportunities, providing inputs and content on the most recent trends.
Nordic Life Science Days attracts leading decision makers from the Life Science sector,
not only from biotech, pharma and medtech but also from finances, research, policy and
regulatory authorities.
More info >> |
|
|
